JPS6234015B2 - - Google Patents
Info
- Publication number
- JPS6234015B2 JPS6234015B2 JP56173360A JP17336081A JPS6234015B2 JP S6234015 B2 JPS6234015 B2 JP S6234015B2 JP 56173360 A JP56173360 A JP 56173360A JP 17336081 A JP17336081 A JP 17336081A JP S6234015 B2 JPS6234015 B2 JP S6234015B2
- Authority
- JP
- Japan
- Prior art keywords
- human placenta
- keloid
- keloids
- present
- placenta extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 208000002260 Keloid Diseases 0.000 claims description 39
- 210000001117 keloid Anatomy 0.000 claims description 39
- 210000002826 placenta Anatomy 0.000 claims description 28
- 239000000284 extract Substances 0.000 claims description 23
- 206010023330 Keloid scar Diseases 0.000 claims description 21
- 239000003814 drug Substances 0.000 claims description 13
- 229940124597 therapeutic agent Drugs 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 11
- 239000002674 ointment Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000008213 purified water Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- -1 Poly Oxyethylene cetyl ether phosphate Polymers 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- 229920002675 Polyoxyl Polymers 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000003871 white petrolatum Substances 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- 206010016334 Feeling hot Diseases 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000002628 heparin derivative Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940105082 medicinal charcoal Drugs 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17336081A JPS5872521A (ja) | 1981-10-28 | 1981-10-28 | ケロイド治療剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17336081A JPS5872521A (ja) | 1981-10-28 | 1981-10-28 | ケロイド治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5872521A JPS5872521A (ja) | 1983-04-30 |
| JPS6234015B2 true JPS6234015B2 (de) | 1987-07-24 |
Family
ID=15958957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17336081A Granted JPS5872521A (ja) | 1981-10-28 | 1981-10-28 | ケロイド治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5872521A (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101828488B1 (ko) * | 2013-05-09 | 2018-02-12 | 이비덴 가부시키가이샤 | 플라센타 추출물 및 그 제조 방법 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5414648A (en) * | 1977-07-05 | 1979-02-03 | Honeywell Inf Systems | Programmable communication controller |
-
1981
- 1981-10-28 JP JP17336081A patent/JPS5872521A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5414648A (en) * | 1977-07-05 | 1979-02-03 | Honeywell Inf Systems | Programmable communication controller |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5872521A (ja) | 1983-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5980875A (en) | Honey preparations | |
| US6171604B1 (en) | Honey preparations | |
| DE2418386C2 (de) | Mittel zur Behandlung von Akne | |
| DE69709682T2 (de) | Gruene salbe | |
| EP0789584B1 (de) | Applikation von sod in liposomen | |
| EP0621787A1 (de) | Mischung zur behandlung der haut aus kalt verarbeitetem aloe vera extrakt, aus dem der gelbe saft und aloin entfernt sind | |
| JP2001504463A (ja) | ククイノキナッツ油を含有する医薬組成物 | |
| US4857328A (en) | Skin therapeutic mixture containing aloe vera extract | |
| US4124720A (en) | Therapeutic hydrodispersible emulsion | |
| JPH08500092A (ja) | 皮膚科用組成物 | |
| US4713242A (en) | Skin therapeutic mixture containing eupatorium extract | |
| JP3995720B2 (ja) | 化粧用ボディーケア調製物およびその製造方法 | |
| JPH039885B2 (de) | ||
| EP0329834A2 (de) | Mittel zur Regeneration und zum Wuchs der Haare sowie zur Heilung und Desinfektion der Haut und Schleimhaut | |
| JPS6360910A (ja) | 皮膚外用剤 | |
| JPS6234015B2 (de) | ||
| WO2003061676A1 (en) | Compositions for and method of treatment for skin ailments | |
| JPS6339813A (ja) | 創傷治療剤 | |
| US4880627A (en) | Skin therapeutic mixture containing eupatorium extract and formulations | |
| WO2021257027A1 (en) | An effective composition in healing wounds | |
| WO2002036130A1 (en) | Veterinary composition for the topical treatment of traumatized or inflamed skin | |
| JP2020152709A (ja) | 皮膚疾患治療剤及びその製造方法 | |
| JPS63313715A (ja) | 髪の成長を刺激するための組成物 | |
| KR960015725B1 (ko) | 모발처리용 조성물 | |
| KR100190233B1 (ko) | 모발처리용 조성물 |